Comparison of the survival between coronary artery bypass graft surgery versus percutaneous coronary intervention in

Shaneel Shah1, Umberto Benedetto2, Massimo Caputo2

  • 1University of Bristol Academy, Bristol Royal Infirmary, Bristol, UK.

Insights

Coronary artery bypass graft (CABG) surgery offers superior long-term survival benefits compared to percutaneous coronary intervention (PCI) for patients with poor left ventricular function (LVF). Despite a longer hospital stay, CABG significantly reduces mortality risk in this vulnerable patient group.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Limited evidence exists comparing coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) for patients with poor left ventricular function (LVF).
  • Previous studies often excluded patients with poor LVF or did not account for modern PCI techniques like drug-eluting stents.

Purpose of the Study:

  • To compare the long-term outcomes of CABG versus PCI in patients with severely impaired left ventricular function (ejection fraction <30%).
  • To evaluate the comparative effectiveness of revascularization strategies in a high-risk cardiac population.

Main Methods:

  • A propensity score analysis was used to match 67 patients who underwent CABG with 67 patients who underwent PCI.
  • Data from 717 patients with LVF (ejection fraction <30%) treated between 2002 and 2015 were analyzed.
  • Outcomes were assessed using national registry data, with a focus on 8-year mortality rates.

Main Results:

  • CABG patients had a significantly longer hospital stay (7 days vs. 2 days) compared to PCI patients.
  • PCI was associated with a higher adjusted 8-year mortality rate (hazard ratio 3.291, P < 0.001).
  • Both on-pump and off-pump CABG demonstrated superior survival outcomes compared to PCI in patients with poor LVF.

Conclusions:

  • Coronary artery bypass graft (CABG) surgery is a superior revascularization strategy to percutaneous coronary intervention (PCI) for patients with poor left ventricular function.
  • Despite increased initial hospitalization, CABG provides significant long-term survival benefits for this high-risk group.
  • The findings support CABG as the preferred treatment modality for coronary artery disease in patients with impaired LVF.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
504
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
292
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
404
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
709
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.4K